Nasus Pharma

Powder-based Intra-nasal Products

Active Public Startup Tel Aviv-Yafo Founded 2019-05

Nasus Pharma is developing a number of intranasal powder products aimed at assisting patients in several acute emergency situations (such as opioid overdose and anaphylactic shock) based on its microsphere technology. Nasus's portfolio comprises a number of programs including intranasal naloxone, intranasal epinephrine, and a number of preclinical proof-of-…

SectorHealth Tech & Life Sciences
StagePublic
Total raised$10.0M
Employees6
Founded2019-05
HQTel Aviv-Yafo
Patents1
Confidence90
Sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug Delivery
Technology
Materials & Substances
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals